Loading candles…
Ipca Laboratories Ltd. is a vertically integrated pharmaceutical company engaged in the manufacturing and marketing of pharmaceuticals, including Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company operates in the pharmaceutical industry, serving both the Indian domestic market and various international markets. Its product portfolio includes APIs and FDFs focused on therapeutic areas such as pain management, rheumatology, antimalarials, and cardiovascular health. A significant portion of its revenue is derived from exports. The company’s operations cover the entire value chain in pharmaceuticals, reflecting its integrated business segments of API and FDF manufacturing.
This page is a live market overview for IPCA LABORATORIES LTD (IPCALAB) on the NSE. As a listed security, IPCA LABORATORIES LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for IPCALAB before placing trades on tick2trade.
As of the latest feed, IPCALAB last traded at ₹1,735.8 on NSE, up ₹1.6 (0.09%) from the previous close of ₹1,734.2. Today's session range is ₹1,711.7 – ₹1,745, against a 52-week band of ₹1,251.6 – ₹1,944.9. Traded volume today stands at 79.83K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for IPCALAB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether IPCALAB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for IPCA LABORATORIES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in IPCALAB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated IPCALAB option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 13 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 29 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 13 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 13 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 11 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and Final dividend | 29 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.